Destiny Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Buy
693
+136
+24% +$46.6K 0.04% 133
2026
Q1
$196K Buy
+557
New +$199K 0.02% 231
2023
Q1
Sell
-1,147
Closed -$301K 203
2022
Q4
$301K Sell
1,147
-124
-10% -$33.2K 0.07% 155
2022
Q3
$286K Buy
1,271
+308
+32% +$74.7K 0.06% 144
2022
Q2
$234K Buy
963
+402
+72% +$98.5K 0.05% 142
2022
Q1
$136K Buy
561
+527
+1,550% +$121K 0.03% 192
2021
Q4
$8K Hold
34
﹤0.01% 456
2021
Q3
$7K Buy
+34
New +$7.83K ﹤0.01% 438
2021
Q2
Sell
-51
Closed -$13K 197
2021
Q1
$13K Buy
51
+17
+50% +$4.06K ﹤0.01% 388
2020
Q4
$8K Buy
+34
New +$7.84K ﹤0.01% 423

Other funds holding AMGN

Destiny Wealth Partners's AMGN Position: Q2 2026 in Review

Destiny Wealth Partners increased its Amgen (AMGN) stake by 24% in Q2 2026, buying an estimated $46.6K and bringing the position to 693 shares worth $267K. The position accounts for 0.04% of the portfolio, ranked #133.

Destiny Wealth Partners first reported a position in AMGN in Q4 2020 and has held it in 10 quarters since. The position peaked at $301K in Q4 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Destiny Wealth Partners held 693 shares of Amgen worth $267K as of Q2 2026.
  • Destiny Wealth Partners bought 136 Amgen shares in Q2 2026, an estimated $46.6K.
  • Amgen made up 0.04% of Destiny Wealth Partners's portfolio in Q2 2026, its #133 holding.
  • Destiny Wealth Partners first reported a position in Amgen in Q4 2020 and has held it in 10 quarters since.
  • Destiny Wealth Partners's Amgen position peaked at $301K in Q4 2022.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.